
Amicus Therapeutics CEO John Crowley
Goldman Sachs Talks
00:00
What Was the Biggest Challenge During Covet?
Goldmensax: Over the last year, we, as a firm, wese a team. We may play a very small role in that ecosystem, but that very small role is still a thrill. It shows that every little piece of the system came together last year to the point where many of ou colleagues are family members and people in new york city now 've all been going to jab twice. So i thank you for that. A you're making me. Vor clem, never were tuar word said, john, i just, i feel like one of the biggest thrills of my career.
Transcript
Play full episode